Trinity Fundamentals

TRIB
 Stock
  

USD 1.40  0.04  2.94%   

Trinity Bio ADR fundamentals help investors to digest information that contributes to Trinity Bio's financial success or failures. It also enables traders to predict the movement of Trinity Stock. The fundamental analysis module provides a way to measure Trinity Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trinity Bio stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Trinity Shares Owned by Insiders Analysis

Trinity Bio's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Insiders Shares 
 = 
Executives Shares 
Employees 
More About Shares Owned by Insiders | All Equity Analysis

Current Trinity Bio Shares Owned by Insiders

    
  11.63 %  
Most of Trinity Bio's fundamental indicators, such as Shares Owned by Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trinity Bio ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Compare to competition

Based on the latest financial disclosure, 11.63% of Trinity Bio ADR are shares owned by insiders. This is 23.39% lower than that of the Healthcare sector and 24.38% lower than that of the Diagnostics & Research industry. The shares owned by insiders for all United States stocks is 15.26% lower than that of the firm.

Trinity Bio ADR Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Trinity Bio's current stock value. Our valuation model uses many indicators to compare Trinity Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Trinity Bio competition to find correlations between indicators driving Trinity Bio's intrinsic value. More Info.
Trinity Bio ADR is currently regarded as top stock in short ratio category among related companies. It is currently regarded as top stock in current liabilities category among related companies creating about  2,554,745  of Current Liabilities per Short Ratio. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Trinity Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Trinity Bio's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Trinity Bio's earnings, one of the primary drivers of an investment's value.

Trinity Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trinity Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Trinity Bio could also be used in its relative valuation, which is a method of valuing Trinity Bio by comparing valuation metrics of similar companies.
Trinity Bio is currently under evaluation in current valuation category among related companies.

Trinity Fundamentals

About Trinity Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Trinity Bio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trinity Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trinity Bio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market in the Americas, Africa, Asia, and Europe. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland. Trinity Bio operates under Pharmaceuticals And Biosciences classification in the United States and is traded on NASDAQ Exchange. It employs 477 people.

Trinity Bio Investors Sentiment

The influence of Trinity Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Trinity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Trinity Bio Implied Volatility

    
  336.75  
Trinity Bio's implied volatility exposes the market's sentiment of Trinity Bio ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Trinity Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Trinity Bio stock will not fluctuate a lot when Trinity Bio's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Trinity Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Trinity Bio's short interest history, or implied volatility extrapolated from Trinity Bio options trading.

Currently Active Assets on Macroaxis

Additionally, take a look at Trinity Bio Piotroski F Score and Trinity Bio Altman Z Score analysis. Note that the Trinity Bio ADR information on this page should be used as a complementary analysis to other Trinity Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Trinity Stock analysis

When running Trinity Bio ADR price analysis, check to measure Trinity Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Bio is operating at the current time. Most of Trinity Bio's value examination focuses on studying past and present price action to predict the probability of Trinity Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Trinity Bio's price. Additionally, you may evaluate how the addition of Trinity Bio to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Is Trinity Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Bio. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.77
Market Capitalization
53 M
Quarterly Revenue Growth YOY
-0.27
Return On Assets
0.031
Return On Equity
-1.91
The market value of Trinity Bio ADR is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Bio's value that differs from its market value or its book value, called intrinsic value, which is Trinity Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Bio's market value can be influenced by many factors that don't directly affect Trinity Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Trinity Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.